Hartford HealthCare Corp:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Hartford HealthCare Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10518
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Hartford HealthCare Corp (HHC) is a healthcare service provider that offers clinical care, education and research services. The organization’s services include behavioral and mental health, bone and joint care, cancer, cardiology and heart care, dermatology, diabetes and endocrinology, digestive health, ear, nose and throat, and emergency services. It also provides senior services, sleep disorders, sports medicine, stroke, surgical weight loss, transplant services, urgent care, urology and kidney, women’s health and wound care, among others. HHC offers its services through a network of hospitals, medical labs, behavioral health centers, long-term nursing and rehabilitation facilities and several community programs, among others. The organization provides clinical trials, education and research, employee tools for healthcare professionals. HHC is headquartered in Hartford, Connecticut, the US.

Hartford HealthCare Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Hartford HealthCare Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Hartford HealthCare Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Hartford HealthCare Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Hartford HealthCare Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Hartford HealthCare Corp, Medical Devices Deals, 2012 to YTD 2018 9
Hartford HealthCare Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Hartford HealthCare Corp, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Hartford HealthCare to Acquire St. Vincent’s Medical Center from Ascension 11
Acquisition 12
Rennova Health Acquires 15% stake in Genomas from Hartford Healthcare 12
Hartford HealthCare To Acquire Backus, Healthcare Services Provider 13
Hartford HealthCare Corp – Key Competitors 14
Hartford HealthCare Corp – Key Employees 15
Hartford HealthCare Corp – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Legal and Regulatory 18
Dec 13, 2017: Hartford HealthCare-GoHealth Urgent Care Receives Accreditation from the Urgent Care Association of America 18
Government and Public Interest 19
Jan 30, 2017: Hartford HealthCare Neuroscience Institute Receives Transformational Gifts 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Hartford HealthCare Corp, Pharmaceuticals & Healthcare, Key Facts 2
Hartford HealthCare Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Hartford HealthCare Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Hartford HealthCare Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Hartford HealthCare Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Hartford HealthCare Corp, Medical Devices Deals, 2012 to YTD 2018 9
Hartford HealthCare Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Hartford HealthCare to Acquire St. Vincent's Medical Center from Ascension 11
Rennova Health Acquires 15% stake in Genomas from Hartford Healthcare 12
Hartford HealthCare To Acquire Backus, Healthcare Services Provider 13
Hartford HealthCare Corp, Key Competitors 14
Hartford HealthCare Corp, Key Employees 15

List of Figures
Hartford HealthCare Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Hartford HealthCare Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Hartford HealthCare Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Hartford HealthCare Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Hartford HealthCare Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Hartford HealthCare Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Hartford HealthCare Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Hartford HealthCare Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Hartford HealthCare Corp, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Hartford HealthCare Corp:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sierra Oncology Inc (SRRA):医療機器:M&Aディール及び事業提携情報
    Summary Sierra Oncology Inc (Sierra Oncology), formerly ProNAi Therapeutics Inc is a clinical stage drug development company that develops and commercializes DNA damage response therapeutics for the treatment of cancer. The company’s product candidate includes SRA737, an orally bioavailable small mo …
  • Powszechny Zaklad Ubezpieczen Group:企業の戦略・SWOT・財務情報
    Powszechny Zaklad Ubezpieczen Group - Strategy, SWOT and Corporate Finance Report Summary Powszechny Zaklad Ubezpieczen Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Qc Holdings Inc:企業の戦略・SWOT・財務分析
    Qc Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Qc Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Miracor Medical Systems GmbH:製品パイプライン分析
    Summary Miracor Medical Systems GmbH (Miracor Medical) is a medical device company that develops and commercializes pressure-controlled intermittent coronary sinus occlusions. The company offers products for continuous monitoring of coronary sinus pressure dynamics. It offers impulse console and imp …
  • Schott AG:企業の戦略的SWOT分析
    Schott AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Optimum General Inc.
    Optimum General Inc. - Strategy, SWOT and Corporate Finance Report Summary Optimum General Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Almac Diagnostics Ltd:製品パイプライン分析
    Summary Almac Diagnostics Ltd (Almac Diagnostics), formerly ArraDx Ltd, a subsidiary of Almac Group Ltd, medical diagnostic company that discovers, develops and commercializes diagnostic tests including companion diagnostics. The company’s products pipeline includes ColDx, DDRD, AADx, prostate Dx, a …
  • SK Innovation Co Ltd (096770):石油・ガス:M&Aディール及び事業提携情報
    Summary SK Innovation Co Ltd (SK Innovation) is an integrated energy and petrochemical company. It explores for and produces crude oil and natural gas; transportation of crude oil; and production of oil products such as gasoline and diesel. Through subsidiaries, the company carries out refining oper …
  • The Jean Coutu Group (PJC) Inc.:企業の戦略・SWOT・財務分析
    The Jean Coutu Group (PJC) Inc. - Strategy, SWOT and Corporate Finance Report Summary The Jean Coutu Group (PJC) Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Nigeria LNG Ltd:企業の戦略的SWOT分析
    Nigeria LNG Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Regen BioPharma Inc (RGBP):企業の財務・戦略的SWOT分析
    Summary Regen BioPharma Inc (Regen BioPharma), a subsidiary of Bio-Matrix Scientific Group Inc, is an immunology and immunotherapy space provider. The company concentrates on the development of immunotherapies and cancer stem cell therapies. Its product pipeline includes HemaXellerate, dCellVax, Dif …
  • Sadbhav Engineering Ltd:企業の戦略・SWOT・財務情報
    Sadbhav Engineering Ltd - Strategy, SWOT and Corporate Finance Report Summary Sadbhav Engineering Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • NRW Holdings Ltd:企業の戦略・SWOT・財務情報
    NRW Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary NRW Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Standard Chem & Pharm Co Ltd:企業の戦略・SWOT・財務情報
    Standard Chem & Pharm Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Standard Chem & Pharm Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Reyes Holdings, L.L.C.:企業の戦略・SWOT・財務分析
    Reyes Holdings, L.L.C. - Strategy, SWOT and Corporate Finance Report Summary Reyes Holdings, L.L.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Arkema SA:企業の戦略・SWOT・財務分析
    Arkema SA - Strategy, SWOT and Corporate Finance Report Summary Arkema SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Finning International Inc. (FTT):企業の財務・戦略的SWOT分析
    Finning International Inc. (FTT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Quest Diagnostics Inc (DGX)-製薬・医療分野:企業M&A・提携分析
    Summary Quest Diagnostics Inc (Quest Diagnostics) is a provider of diagnostic information services to patients and physicians through a chain of laboratories and company-owned patient service centers. It offers comprehensive range of services including clinical testing with gene-based and other esot …
  • Alternatifbank A.S.
    Alternatifbank A.S. - Strategy, SWOT and Corporate Finance Report Summary Alternatifbank A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Blaze Bioscience Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Blaze Bioscience Inc (Blaze) is a biotechnology company that offers guided cancer therapy solutions. The company develops tumor paint products and optide-based guided cancer therapeutics. It provides cancer surgery by development of real-time, high-resolution view of cancer cell technologies …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆